Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing

OBJECTIVE: To determine the most cost-effective screening programme for cervical cancer. DESIGN: Cost-effectiveness analysis from a societal perspective. SETTING: The Netherlands. POPULATION: Dutch women who have not been invited for human papillomavirus (HPV) vaccination. METHODS: We calibrated the...

Descripción completa

Detalles Bibliográficos
Autores principales: van Rosmalen, J, de Kok, IMCM, van Ballegooijen, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489039/
https://www.ncbi.nlm.nih.gov/pubmed/22251259
http://dx.doi.org/10.1111/j.1471-0528.2011.03228.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489039/
https://www.ncbi.nlm.nih.gov/pubmed/22251259
http://dx.doi.org/10.1111/j.1471-0528.2011.03228.x

Ejemplares similares